From: Mycoplasma haemocanis – the canine hemoplasma and its feline counterpart in the genomic era
Role Category | Number of CDSs (%) | |
---|---|---|
M. haemocanis str. Illinois | M. haemofelis str. Ohio2 | |
Purines, pyrimidines, nucleosides, and nucleotides | 33 (2.81%) | 29 (1.85%) |
Fatty acid and phospholipid metabolism | 6 (0.51%) | 6 (0.38%) |
Biosynthesis of co-factors, prosthetic groups, and carriers | 8 (0.68%) | 7 (0.45%) |
Central intermediary metabolism | 1 (0.09%) | 1 (0.06%) |
Energy metabolism | 25 (2.13%) | 22 (1.41%) |
Transport and binding proteins | 35 (2.98%) | 32 (2.04%) |
DNA metabolism | 44 (3.75%) | 52 (3.32%) |
Transcription | 21 (1.79%) | 18 (1.15%) |
Protein synthesis | 96 (8.18%) | 97 (6.2%) |
Protein fate | 21 (1.79%) | 19 (1.21%) |
Regulatory functions | 4 (0.34%) | 3 (0.19%) |
Signal transduction | 3 (0.26%) | 2 (0.13%) |
Cell envelope | 3 (0.26%) | 7 (0.45%) |
Cellular processes | 14 (1.19%) | 10 (0.64%) |
Unknown functions | 8 (0.68%) | 8 (0.51%) |
Hypothetical proteins | 887 (75.62%) | 1253 (80.06%) |
Total* | 1209 | 1566 |